Wolfe RA - Search Results

1

Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study.

Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, Burrows-Hudson S, Messana JM, Levin N, Rajagopalan S, Port FK, Wolfe RA, Saran R. Perlman RL, et al. Among authors: wolfe ra. Am J Kidney Dis. 2005 Apr;45(4):658-66. doi: 10.1053/j.ajkd.2004.12.021. Am J Kidney Dis. 2005. PMID: 15806468

2

Impact of years of dialysis therapy on mortality risk and the characteristics of longer term dialysis survivors.

Okechukwu CN, Lopes AA, Stack AG, Feng S, Wolfe RA, Port FK. Okechukwu CN, et al. Among authors: wolfe ra. Am J Kidney Dis. 2002 Mar;39(3):533-8. doi: 10.1053/ajkd.2002.31403. Am J Kidney Dis. 2002. PMID: 11877572

3

Lack of correlation between facility-based standardized rates of transplantation and mortality.

Okechukwu CN, Hulbert-Shearon TE, Wiggins RC, Wolfe RA, Port FK. Okechukwu CN, et al. Among authors: wolfe ra. Am J Kidney Dis. 2002 Aug;40(2):381-4. doi: 10.1053/ajkd.2002.34528. Am J Kidney Dis. 2002. PMID: 12148112

4

High dialysis dose is associated with lower mortality among women but not among men.

Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ. Port FK, et al. Among authors: wolfe ra. Am J Kidney Dis. 2004 Jun;43(6):1014-23. doi: 10.1053/j.ajkd.2004.02.014. Am J Kidney Dis. 2004. PMID: 15168381 Clinical Trial.

5

Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002.

Wolfe RA, Hulbert-Shearon TE, Ashby VB, Mahadevan S, Port FK. Wolfe RA, et al. Am J Kidney Dis. 2005 Jan;45(1):127-35. doi: 10.1053/j.ajkd.2004.09.023. Am J Kidney Dis. 2005. PMID: 15696452

6

Understanding the basic case-mix adjustment for the composite rate.

Wheeler JR, Messana JM, Turenne MN, Hirth RA, Pozniak AS, Pan Q, Chuang CC, Slish K, Tedeschi P, Roys EC, Wolfe RA. Wheeler JR, et al. Among authors: wolfe ra. Am J Kidney Dis. 2006 Apr;47(4):666-71. doi: 10.1053/j.ajkd.2005.12.037. Am J Kidney Dis. 2006. PMID: 16564944

7

Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis.

Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK. Pisoni RL, et al. Among authors: wolfe ra. Am J Kidney Dis. 2009 Mar;53(3):475-91. doi: 10.1053/j.ajkd.2008.10.043. Epub 2009 Jan 15. Am J Kidney Dis. 2009. PMID: 19150158

8

Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practices.

Pisoni RL, Bragg-Gresham JL, Fuller DS, Morgenstern H, Canaud B, Locatelli F, Li Y, Gillespie B, Wolfe RA, Port FK, Robinson BM. Pisoni RL, et al. Among authors: wolfe ra. Am J Kidney Dis. 2011 Feb;57(2):266-75. doi: 10.1053/j.ajkd.2010.11.003. Am J Kidney Dis. 2011. PMID: 21251541

9

Recovery from end-stage renal disease.

Sekkarie MA, Port FK, Wolfe RA, Guire K, Humphrys R, Van Amburg G, Ferguson CW. Sekkarie MA, et al. Among authors: wolfe ra. Am J Kidney Dis. 1990 Jan;15(1):61-5. doi: 10.1016/s0272-6386(12)80593-2. Am J Kidney Dis. 1990. PMID: 2294734

10

A comparison of survival among dialytic therapies of choice: in-center hemodialysis versus continuous ambulatory peritoneal dialysis at home.

Wolfe RA, Port FK, Hawthorne VM, Guire KE. Wolfe RA, et al. Am J Kidney Dis. 1990 May;15(5):433-40. doi: 10.1016/s0272-6386(12)70361-x. Am J Kidney Dis. 1990. PMID: 2333865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page